Pierre‐Paul Bringuier
Lyon 1 Université · 125 works · 5,146 citations · h-index 31
Top works
- Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)
- Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.
- Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors.
- Role of E Boxes in the Repression of E-Cadherin Expression
- Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
- Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors.
- Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization.
- Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification.
- BRAFMutation Status in Gastrointestinal Stromal Tumors
- KIT and PDGFRA Mutations and the Risk of GI Stromal Tumor Recurrence
- Complex cadherin expression in renal cell carcinoma.
- Predictive Value of Biological Markers for Hepatocellular Carcinoma Patients Treated with Orthotopic Liver Transplantation
- Changes in cadherin‐catenin complexes in the progression of human bladder carcinoma
- Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs
- Melanoma Patients under Vemurafenib: Prospective Follow-Up of Melanocytic Lesions by Digital Dermoscopy
- Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations
- Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma.
- Astrocytomas and Choroid Plexus Tumors in Two Families with Identical p53 Germline Mutations
- p53 mutations have no additional prognostic value over stage in bladder cancer
- Comparison of P53 protein overexpression with P53 mutation in bladder cancer: clinical and biologic aspects.